Medical oncologist Rona Yaeger (right) studies signaling pathways in colorectal cancer.
Researchers at Memorial Sloan Kettering are exploring new therapies and diagnostic tools for colon and rectal cancer. If you qualify, your treatment team can recommend one of our clinical trials if they feel it may help improve your condition.
Hereditary Colorectal Cancer Family Registry
MSK has established a registry for families who are affected by various types of hereditary colorectal cancer syndromes. The registry is allowing researchers to learn more about the genetic causes of colorectal cancer. It is also helping in the development of new ways to prevent, diagnose, and treat cancers of the colon and rectum.
If you enroll in the registry, you’ll be asked to complete a questionnaire about your family history of cancer. You may also have blood and tissue samples collected as part of another study. Information from these tests can be combined with data from the questionnaire to learn more about hereditary colorectal cancer syndromes. You may be contacted periodically over the next several years so that researchers can follow up on your health status.
By participating in the MSK Hereditary Colorectal Cancer Registry, you can learn more about your risk for colorectal and other cancers. The registry can also allow you to have increased surveillance if you are at risk. If you have already been diagnosed with a hereditary colorectal cancer syndrome, the registry can keep you up-to-date on new research that may affect your medical care. Our researchers are working on many projects to learn more about these syndromes. Additionally, several other studies may be open to patients enrolled in the registry.
For more information about the Hereditary Colorectal Cancer Registry, contact:
Rupa Sood, MSc
Registrar/Research Project Coordinator
Department of Surgery/Colorectal